13F HOLDINGS REPORT
Prosight Management, LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001420506-25-002021
Total Value
$410.1M
Positions
39
Other Managers
0
Confidential Omitted
No
Holdings (39)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | GALAPAGOS NV | GLPGF | 1,773,649 | $49.6M | 12.11% |
| 2 | UNITEDHEALTH GROUP INC | UNH | 110,000 | $34.3M | 8.37% |
| 3 | MEIRAGTX HLDGS PLC | MGTX | 4,587,423 | $29.9M | 7.29% |
| 4 | ADC THERAPEUTICS SA | ADCT | 10,467,771 | $28.1M | 6.84% |
| 5 | BRIDGEBIO PHARMA INC | BBIO | 472,687 | $20.4M | 4.98% |
| 6 | ROIVANT SCIENCES LTD | ROIV | 1,808,539 | $20.4M | 4.97% |
| 7 | AMICUS THERAPEUTICS INC | FOLD | 3,480,044 | $19.9M | 4.86% |
| 8 | JANUX THERAPEUTICS INC | JANX | 853,904 | $19.7M | 4.81% |
| 9 | KURA ONCOLOGY INC | KURA | 3,181,184 | $18.4M | 4.48% |
| 10 | ZYMEWORKS INC | ZYME | 1,309,904 | $16.4M | 4.01% |
| 11 | ICON PLC | ICLR | 98,558 | $14.3M | 3.50% |
| 12 | ARGENX SE | ARGX | 22,000 | $12.1M | 2.96% |
| 13 | MIRUM PHARMACEUTICALS INC | MIRM | 200,000 | $10.2M | 2.48% |
| 14 | SYNDAX PHARMACEUTICALS INC | SNDX | 1,079,673 | $10.1M | 2.47% |
| 15 | TECTONIC THERAPEUTIC INC | TECX | 442,056 | $8.8M | 2.14% |
| 16 | CRINETICS PHARMACEUTICALS IN | CRNX | 298,123 | $8.6M | 2.09% |
| 17 | CYTOMX THERAPEUTICS INC | CTMX | 3,517,113 | $8.0M | 1.95% |
| 18 | IMMUNOVANT INC | IMVT | 479,400 | $7.7M | 1.87% |
| 19 | BIOHAVEN LTD | BHVN | 539,071 | $7.6M | 1.85% |
| 20 | CONCENTRA GROUP HOLDINGS PAR | CON | 312,105 | $6.4M | 1.57% |
| 21 | LIVANOVA PLC | LIVN | 140,000 | $6.3M | 1.54% |
| 22 | DEXCOM INC | DXCM | 70,000 | $6.1M | 1.49% |
| 23 | CAREDX INC | CDNA | 302,808 | $5.9M | 1.44% |
| 24 | SELECT MED HLDGS CORP | 81619Q105 | 353,820 | $5.4M | 1.31% |
| 25 | SHATTUCK LABS INC | STTK | 6,638,935 | $5.3M | 1.28% |
| 26 | ACADIA HEALTHCARE COMPANY IN | ACHC | 211,816 | $4.8M | 1.17% |
| 27 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 579,893 | $4.0M | 0.98% |
| 28 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,580,588 | $3.9M | 0.94% |
| 29 | SIGHT SCIENCES INC | SGHT | 871,687 | $3.6M | 0.88% |
| 30 | AXOGEN INC | AXGN | 282,809 | $3.1M | 0.75% |
| 31 | LANTHEUS HLDGS INC | LNTH | 34,576 | $2.8M | 0.69% |
| 32 | MURAL ONCOLOGY PUB LTD CO | G63365103 | 900,000 | $2.2M | 0.54% |
| 33 | PROTHENA CORP PLC | PRTA | 267,800 | $1.6M | 0.40% |
| 34 | ORTHOPEDIATRICS CORP | KIDS | 73,647 | $1.6M | 0.39% |
| 35 | PLIANT THERAPEUTICS INC | PLRX | 837,400 | $971,384 | 0.24% |
| 36 | REIN THERAPEUTICS INC | RNTX | 427,919 | $599,087 | 0.15% |
| 37 | ONKURE THERAPEUTICS INC | OKUR | 159,692 | $381,664 | 0.09% |
| 38 | ERASCA INC | ERAS | 240,295 | $305,175 | 0.07% |
| 39 | PEPGEN INC | PEPG | 243,980 | $270,818 | 0.07% |